Observations and findings during the development of a subnormothermic/normothermic long-term ex vivo liver perfusion machine

被引:4
作者
Schuler, Martin J. [1 ]
Becker, Dustin [1 ]
Mueller, Matteo [2 ]
Bautista Borrego, Lucia [2 ]
Mancina, Leandro [2 ]
Huwyler, Florian [3 ]
Binz, Jonas [1 ]
Hagedorn, Catherine [2 ]
Schaer, Beatrice [4 ]
Gygax, Erich [5 ]
Weisskopf, Miriam [6 ]
Sousa Da Silva, Richard Xavier [2 ]
Antunes Crisostomo, Joao Miguel [1 ]
Dutkowski, Philipp [2 ]
Rudolf von Rohr, Philipp [7 ]
Clavien, Pierre-Alain [2 ]
Tibbitt, Mark W. [3 ]
Eshmuminov, Dilmurodjon [2 ]
Hefti, Max [1 ]
机构
[1] Univ Zurich, Wyss Zurich ETH Zurich, CH-8092 Zurich, Switzerland
[2] Univ Hosp Zurich, Dept Surg, Swiss Hepato Pancreato Biliary & Transplantat Ctr, Zurich, Switzerland
[3] Swiss Fed Inst Technol, Dept Mech & Proc Engn, Macromol Engn Lab, Zurich, Switzerland
[4] Securecell AG, Entwicklung Biomed Anwendungen, Urdorf, Switzerland
[5] Fumed AG, Forsch & Entwicklung, Muri, Switzerland
[6] Univ Zurich, Univ Zurich Hosp, Surg Res Ctr, Zurich, Switzerland
[7] Swiss Fed Inst Technol, Dept Mech & Proc Engn, Transport Proc & React Lab, Zurich, Switzerland
关键词
clearance; free hemoglobin; hemolysis; lactate; liver perfusion; long-term perfusion; perfusion parameters; subnormothermic; normothermic perfusion; CARDIOPULMONARY BYPASS; BLOOD; TRANSPLANTATION; PRESERVATION; METABOLISM; PULSATILE; MICROCIRCULATION; HEMOGLOBIN; DELIVERY; ORGAN;
D O I
10.1111/aor.14403
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Background Ex situliver machine perfusion at subnormothermic/normothermic temperature isincreasingly applied in the field of transplantation to store and evaluateorgans on the machine prior transplantation. Currently, various perfusionconcepts are in clinical and preclinical applications. Over the last 6 years ina multidisciplinary team, a novel blood based perfusion technology wasdeveloped to keep a liver alive and metabolically active outside of the bodyfor at least one week. Methods Within thismanuscript, we present and compare three scenarios (Group 1, 2 and 3) we werefacing during our research and development (R&D) process, mainly linked tothe measurement of free hemoglobin and lactate in the blood based perfusate. Apartfrom their proven value in liver viability assessment (ex situ), these twoparameters are also helpful in R&D of a long-term liver perfusion machine and moreover supportive in the biomedical engineering process. Results Group 1 ("good" liver on the perfusion machine) represents the best liver clearance capacity for lactate and free hemoglobin wehave observed. In contrast to Group 2 ("poor" liver on the perfusion machine), that has shown the worst clearance capacity for free hemoglobin. Astonishingly,also for Group 2, lactate is cleared till the first day of perfusion andafterwards, rising lactate values are detected due to the poor quality of theliver. These two perfusate parametersclearly highlight the impact of the organ quality/viability on the perfusion process. Whereas Group 3 is a perfusion utilizing a blood loop only (without a liver). Conclusion Knowing the feasible ranges (upper- and lower bound) and the courseover time of free hemoglobin and lactate is helpful to evaluate the quality ofthe organ perfusion itself and the maturity of the developed perfusion device. Freehemoglobin in the perfusate is linked to the rate of hemolysis that indicates how optimizing (gentle blood handling, minimizing hemolysis) the perfusion machine actually is. Generally, a reduced lactate clearancecapacity can be an indication for technical problems linked to the blood supplyof the liver and therefore helps to monitor the perfusion experiments.Moreover, the possibility is given to compare, evaluate and optimize developed liverperfusion systems based on the given ranges for these two parameters. Otherresearch groups can compare/quantify their perfusate (blood) parameters withthe ones in this manuscript. The presented data, findings and recommendations willfinally support other researchers in developing their own perfusion machine ormodifying commercially availableperfusion devices according to their needs.
引用
收藏
页码:317 / 329
页数:13
相关论文
共 50 条
  • [21] The Rationale for Combining Normothermic Liver Machine Perfusion with Continuous Renal Replacement Therapy to Maintain Physiological Perfusate during Ex Vivo Organ Perfusion
    Nalesso, Federico
    Bertacco, Alessandra
    Bettin, Elisabetta
    Cacciapuoti, Martina
    Bogo, Marco
    Cattarin, Leda
    Lanari, Jacopo
    Furlanetto, Alessandro
    Lanubile, Alessia
    Gringeri, Enrico
    Calo, Lorenzo A.
    Cillo, Umberto
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (17)
  • [22] Normothermic Ex-vivo Liver Perfusion and the Clinical Implications for Liver Transplantation
    Akateh, Clifford
    Beal, Eliza W.
    Whitson, Bryan A.
    Black, Sylvester M.
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2018, 6 (03) : 276 - 282
  • [23] Long-term ex situ normothermic perfusion of human split livers for more than 1 week
    Lau, Ngee-Soon
    Ly, Mark
    Dennis, Claude
    Jacques, Andrew
    Cabanes-Creus, Marti
    Toomath, Shamus
    Huang, Joanna
    Mestrovic, Nicole
    Yousif, Paul
    Chanda, Sumon
    Wang, Chuanmin
    Lisowski, Leszek
    Liu, Ken
    Kench, James G.
    McCaughan, Geoffrey
    Crawford, Michael
    Pulitano, Carlo
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [24] Ex vivo Normothermic Machine Perfusion and Viability Testing of Discarded Human Donor Livers
    op den Dries, S.
    Karimian, N.
    Sutton, M. E.
    Westerkamp, A. C.
    Nijsten, M. W. N.
    Gouw, A. S. H.
    Wiersema-Buist, J.
    Lisman, T.
    Leuvenink, H. G. D.
    Porte, R. J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (05) : 1327 - 1335
  • [25] Editorial: Ex vivo Liver Machine Perfusion
    Nickkholgh, Arash
    Maluf, Daniel G.
    Schemmer, Peter
    FRONTIERS IN SURGERY, 2022, 9
  • [26] Long-term ex situ normothermic machine perfusion allows regeneration of human livers with severe bile duct injury
    Ly, Mark
    Lau, Ngee-Soon
    Dennis, Claude
    Chen, Jinbiao
    Risbey, Charles
    Tan, Sarah
    Chen, Renfen
    Wang, Chuanmin
    Gorrell, Mark D.
    Mckenzie, Catriona
    Kench, James G.
    Liu, Ken
    Mccaughan, Geoffrey W.
    Crawford, Michael
    Pulitano, Carlo
    AMERICAN JOURNAL OF TRANSPLANTATION, 2025, 25 (01) : 60 - 71
  • [27] The role of normothermic machine perfusion (NMP) in the preservation of ex-vivo liver before transplantation: A review
    Shen, Chuanyan
    Cheng, Hongwei
    Zong, Tingting
    Zhu, Hongli
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2023, 11
  • [28] Viability Criteria during Liver Ex-Situ Normothermic and Hypothermic Perfusion
    Melandro, Fabio
    De Carlis, Riccardo
    Torri, Francesco
    Lauterio, Andrea
    De Simone, Paolo
    De Carlis, Luciano
    Ghinolfi, Davide
    MEDICINA-LITHUANIA, 2022, 58 (10):
  • [29] Addressing the Donor Liver Shortage with EX VIVO Machine Perfusion
    Izamis, Maria-Louisa
    Berendsen, Tim A.
    Uygun, Korkut
    Yarmush, Martin L.
    JOURNAL OF HEALTHCARE ENGINEERING, 2012, 3 (02) : 279 - 297
  • [30] Interleukin-10 and Transforming Growth Factor-β Cytokines Decrease Immune Activation During Normothermic Ex Vivo Machine Perfusion of the Rat Liver
    Carlson, Kristin N.
    Pavan-Guimaraes, Juliana
    Verhagen, Joshua C.
    Chlebeck, Peter
    Verhoven, Bret
    Jennings, Heather
    Najmabadi, Feridoon
    Liu, Yongjun
    Burlingham, William
    Capitini, Christian M.
    Al-Adra, David P.
    LIVER TRANSPLANTATION, 2021, 27 (11) : 1577 - 1591